NCT06808295View on ClinicalTrials.gov

Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

April 20, 2025

Study Completion Date

May 31, 2025

Conditions
Patients Undergoing External Dacrocystorhinostomy OperationsAssess Decreased Anesthetic Requirements Intraoperative
Interventions
DRUG

Dexmedetomidine Hydrochloride

drug will be given before induction and anesthetic doses and hemodynamics will be assessed pre- intra and postoperative

Trial Locations (1)

Unknown

RECRUITING

Research Institute of Ophthalmolgy, Giza

All Listed Sponsors
lead

Research Institute of Ophthalmology, Egypt

OTHER